コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 relatively healthy individuals with modestly elevated blood pressure.
2 at is initiated by ECD prior to the onset of elevated blood pressure.
3 tamin D insufficiency may be associated with elevated blood pressure.
4 inadequate sleep quality is associated with elevated blood pressure.
5 ponents of the metabolic syndrome except for elevated blood pressure.
6 ved unfair treatment were not a correlate of elevated blood pressure.
7 a2(+/-)), and not alpha1 (alpha1(+/-)), have elevated blood pressure.
8 e lead related to postpartum hypertension or elevated blood pressure.
9 treatment of individuals with substantially elevated blood pressure.
10 e (bone lead) with risks of hypertension and elevated blood pressure.
11 increased transcription rates, resulting in elevated blood pressure.
12 epresent a major advance in the treatment of elevated blood pressure.
13 ce previous concepts of prevention regarding elevated blood pressure.
14 us was not associated cross-sectionally with elevated blood pressure.
15 ted blood glucose, and 23.0% (22.4-23.6) had elevated blood pressure.
16 nclear, especially two of these: obesity and elevated blood pressure.
17 ular dysfunction and mediated partly through elevated blood pressure.
18 ied neighborhood factor on the likelihood of elevated blood pressure.
19 increased stress and anxiety levels and even elevated blood pressure.
20 d for understanding primordial prevention of elevated blood pressure.
21 ioprotective in hypertension by reducing the elevated blood pressure.
22 the epidemiological link between obesity and elevated blood pressure.
23 d 35-70 years with overweight or obesity and elevated blood pressure.
24 se to reduced vascular reactivity and mildly elevated blood pressure.
25 merular filtration rate), and accompanied by elevated blood pressure.
26 lore the effects of positive remodelling and elevated blood pressure.
27 appear to have a causal role in exacerbating elevated blood pressure.
28 -density lipoprotein cholesterol and through elevated blood pressure.
29 ressure in middle-aged and older adults with elevated blood pressure.
30 the cardiovascular risk attributable to the elevated blood pressure.
31 six times in the 10% hypomorphs, which have elevated blood pressure.
32 um retention, global sympathoexcitation, and elevated blood pressure.
33 -beta4 null mice likely contributes to their elevated blood pressure.
34 how that PRCP(gt/gt) mice have significantly elevated blood pressure.
35 with HIV aged 50 or older, 27.5% (n=209 had elevated blood pressure, 13.4% (102) had dysglycaemia, 4
36 -year-old nulliparous woman developed mildly elevated blood pressure (140-150/90-100 mmHg) without pr
37 ification in response to persistent severely elevated blood pressure; (2) non-implementation of presc
39 declines were recorded in the prevalence of elevated blood pressure (27/57 [47%] vs 9/55 [16%]; p=0.
42 was 57.75% for abdominal obesity, 44.05% for elevated blood pressure, 40.98% for reduced HDL-choleste
43 l was highest for HIV (78.1%), and lower for elevated blood pressure (42.5%), active tuberculosis (29
44 ve protein levels (75%), dyslipidemia (50%), elevated blood pressure (49%), impaired fasting glucose
45 tifies valuable results on the prevalence of elevated blood pressure, abnormally high lipid levels (c
47 Furthermore, among the five MetS components, elevated blood pressure (adjusted OR(gamma) = 1.163; 95%
48 isk = 1.60 [95% CI, 1.26-2.03]; P < .01) and elevated blood pressure (adjusted relative risk = 1.48 [
49 orhood variable and the period prevalence of elevated blood pressure, adjusting for individual-level
50 expression is downregulated with chronically elevated blood pressure after angiotensin II infusion.
51 intensive treatment targets in patients with elevated blood pressure after reperfusion with endovascu
53 ver this reduction is likely a result of the elevated blood pressure after the blunting of hypoxic va
54 43-1.60; mid-childhood: 1.76, 1.69-1.91) and elevated blood pressure (age 2 years: 1.07, 1.01-1.13; m
55 17-1.31; mid-childhood: 1.12, 1.06-1.18) and elevated blood pressure (age 2 years: 1.12, 1.06-1.19; m
58 bustly associated with reduced likelihood of elevated blood pressure among White participants but not
59 of a high-salt (HS) diet are independent of elevated blood pressure and are associated with impaired
61 isk of metabolic syndrome, diabetes, angina, elevated blood pressure and biological age, and reduces
63 ns are associated with complications such as elevated blood pressure and decreased creatinine clearan
66 Her vital signs were assessed, and she had elevated blood pressure and increased heart rate and res
67 Deficiency of Kir2.1 channels results in elevated blood pressure and increased vascular resistanc
69 d increase physical activity for people with elevated blood pressure and lipid levels were effective
70 sk factors, including heart disease, stroke, elevated blood pressure and lipid levels, inflammation,
72 orizes a greater proportion of children with elevated blood pressure and PHTN, yet several barriers t
74 bition of CaMKII in the hypothalamus reduces elevated blood pressure and sympathetic nerve discharges
75 the robust body of evidence linking Na with elevated blood pressure and the few existing general pop
76 a functional Npr1 gene coding for NPRA have elevated blood pressures and hearts exhibiting marked hy
77 oxic ventilatory response, LTF of breathing, elevated blood pressures and increased plasma noradrenal
78 isk factors (mainly tobacco use, lipids, and elevated blood pressure) and societal level health deter
79 a non-communicable disease characterized by elevated blood pressure, and a prominent metabolic syndr
80 is of prostaglandin I2 and prostaglandin E2, elevated blood pressure, and accelerated atherogenesis i
82 paired fasting glucose levels, dyslipidemia, elevated blood pressure, and diabetes mellitus) and asso
83 Vpr-Agt-2 developed neither proteinuria nor elevated blood pressure, and displayed minimal glomerula
85 The risk of impaired fasting glucose levels, elevated blood pressure, and elevated high-sensitivity C
86 erence and >2 of the following risk factors: elevated blood pressure, and fasting glucose, triglyceri
88 body mass index, higher waist-to-hip ratio, elevated blood pressure, and inversely associated with n
89 low-density lipoprotein cholesterol, through elevated blood pressure, and possibly also through eleva
90 ucing left ventricular hypertrophy, treating elevated blood pressure, and reducing left ventricular f
91 h and without elevated cholesterol levels or elevated blood pressure, and unhealthy and healthy perso
92 ld increase in mortality risk, comparable to elevated blood pressure, and with a heightened risk of s
93 r filtration rate [GFR] <60 mL/min/1.73 m2), elevated blood pressure (any systolic blood pressure >13
94 mmended work-up in a child who presents with elevated blood pressure as well as innovative evaluation
97 ity changes may enable clinicians to predict elevated blood pressure before its onset and optimize me
99 y assessed the temporal relationship between elevated blood pressure (BP) and arterial stiffness in a
100 rican Academy of Pediatrics guidelines, with elevated blood pressure (BP) and BP percentiles as secon
104 k factors and the underlying genetic risk of elevated blood pressure (BP) determine an individual's c
105 nic and sex disparities in the prevalence of elevated blood pressure (BP) from childhood to adulthood
107 drogenase type 2 (11betaHSD2) contributes to elevated blood pressure (BP) in clinical syndromes, but
118 ined as self-reported physician diagnosis or elevated blood pressure (BP) on measurement, defined as
121 e (CKD) exhibit a disproportionate burden of elevated blood pressure (BP) with a high prevalence of p
123 ertension, but the key period of exposure to elevated blood pressure (BP), and the relative role of s
125 and short sleep duration are associated with elevated blood pressure (BP), possibly through effects o
128 at least 2 consecutive visits with markedly elevated blood pressure (BP; defined as at least 2 conse
132 ol and LDL cholesterol, low HDL cholesterol, elevated blood pressure, cigarette smoking, diabetes, va
135 irds of people over age 60 in North America; elevated blood pressure correlates with increased risk o
137 HFpEF, even in those who continue to have an elevated blood pressure despite treatment with at least
139 131 (26%) had a diagnosis of hypertension or elevated blood pressure documented in the electronic med
146 risk factors, which include hypertension or elevated blood pressure, dyslipidemia, impaired fasting
147 lines have delineated updated thresholds for elevated blood pressure (eBP) in youth and adult guideli
148 of dietary intake with the 15-y incidence of elevated blood pressure (EBP; ie, incident systolic BP >
149 entration was not related to hypertension or elevated blood pressure either in the third trimester or
150 ic kidney disease paralleled by a decline in elevated blood pressure, elevated cholesterol, and previ
151 e risk factors are atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose, a prot
152 factors consist of atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose, a prot
153 haracterized by obesity, insulin resistance, elevated blood pressure, elevated triglycerides, and low
154 rat models of kidney damage associated with elevated blood pressure for the comprehensive analysis o
155 sociated with cardiac risk factors including elevated blood pressure, glucose intolerance, and dyslip
156 y showed symptoms of preeclampsia, including elevated blood pressure, growth-restricted fetuses, and
157 medical center ED for any indication and had elevated blood pressure (>=140/90 mm Hg and <=180/110 mm
159 this study, fewer than 50% of children with elevated blood pressure had a guideline-adherent diagnos
161 failure to intensify therapy in response to elevated blood pressure have not been systematically stu
162 ng, pediatric studies using ABPM to evaluate elevated blood pressure have shown that the prevalence o
163 ed to assess whether the association was via elevated blood pressure, hemoglobin A1c, and high-sensit
164 abetes, or hyperlipidemia) in adult men with elevated blood pressure, hemoglobin A1c, or non-high-den
165 analyses identified positive associations of elevated blood pressure, history of smoking, and type 2
166 d neuropsychological assessments to identify elevated blood pressure, hypercholesterolemia, dysglycem
167 espondents without HF included reductions in elevated blood pressure, hypercholesterolemia, MI, and i
169 blems, Tenth Revision [ICD-10], code I10) or elevated blood pressure (ICD-10 code R03.0) and CDS tool
170 etes in 76% (95% CI, 56 to 97), remission of elevated blood pressure in 74% (95% CI, 64 to 84), and r
171 d that administering ERB agonists suppressed elevated blood pressure in a model of neurogenic hyperte
172 se risk in two case-control studies and with elevated blood pressure in a separate familial study.
173 ted an association between preterm birth and elevated blood pressure in adolescence and young adultho
174 baseline renal function, leaving the role of elevated blood pressure in allograft failure unclear.
175 pression, impaired endothelial function, and elevated blood pressure in animals fed a soy-deficient d
177 elta-1 with gabapentin substantially reduced elevated blood pressure in both FK506-treated WKY and SH
179 ult medicine, but epidemiologic estimates of elevated blood pressure in children and adolescents are
180 nsion and highlight opportunities to address elevated blood pressure in children that could improve l
182 opulation and has been linked to chronically elevated blood pressure in cross-sectional epidemiologic
184 parated TRPV4(SMC) channel subpopulations to elevated blood pressure in hypertension was evaluated in
185 etic variation within FGF1 cosegregates with elevated blood pressure in hypertensive families and tha
186 kbkb) in the mediobasal hypothalamus rapidly elevated blood pressure in mice independently of obesity
189 vide a potential neurovascular mechanism for elevated blood pressure in obstructive sleep apnoea.
190 rauterine lipid exposure was associated with elevated blood pressure in offspring and increased level
191 t maternal hyperlipidemia is associated with elevated blood pressure in offspring and is associated w
193 ular nucleus (PVN) to sympathoexcitation and elevated blood pressure in renovascular hypertension.
194 tor stimulation appears to contribute to the elevated blood pressure in SHR is the rostral ventrolate
196 ests that the development and maintenance of elevated blood pressure in the spontaneously hypertensiv
197 ive association between tobacco exposure and elevated blood pressure in the study population was test
198 s of blood and bone lead on hypertension and elevated blood pressure in the third trimester and postp
199 sted for multiple comparisons P <= .05) with elevated blood pressure in the training data set was rer
201 sts that tobacco exposure is associated with elevated blood pressure in US children and adolescents.
204 ansient and persisting structural effects of elevated blood pressure, in agreement with the scant pat
206 enotype, characterized by pregnancy failure, elevated blood pressure, increased plasma soluble fms-li
210 ors of CVD, namely excess visceral fat (VF), elevated blood pressure, insulin resistance, and atherog
211 adults, age >=18 years with hypertension or elevated blood pressure; intervention: randomized trials
212 me, in turn increasing cardiac output, which elevated blood pressure into the pre-hypertension range.
213 ti-hypertension medications, almost half had elevated blood pressure, irrespective of HIV-status.
216 the kidney to excrete sodium in response to elevated blood pressure is a major contributor to hypert
222 blood pressure lowering accumulated to date, elevated blood pressure is still the leading risk factor
225 ntakes of dietary sodium are associated with elevated blood pressure levels and an increased risk of
226 essure from increasing and can help decrease elevated blood pressure levels for those with high norma
227 of 3 or more of the following risk factors: elevated blood pressure, low high-density lipoprotein ch
228 s a younger population, higher prevalence of elevated blood pressure, lower smoking rates, and lower
230 However, early detection and management of elevated blood pressure may reduce the ultimate burden o
231 ion-study design, 49 adults (56% women) with elevated blood pressure (mean +/- SEM age: 53 +/- 2 y; s
234 female) a third were overweight, 1 in 6 had elevated blood pressure, more than 1 in 10 had high chol
235 high triglycerides, low HDL cholesterol, or elevated blood pressure, most often resulted in a diagno
237 the association between vitamin D status and elevated blood pressure noted in observational studies i
240 ressive disorder characterized by abnormally elevated blood pressure of the pulmonary circulation tha
241 exon for KS-WNK1) exhibited Na(+) retention, elevated blood pressure on a high-Na(+) diet and increas
243 e smoking, overweight and obesity, diabetes, elevated blood pressure or hypertension, dyslipidemia, l
244 ctors, including smoking, obesity, diabetes, elevated blood pressure or hypertension, dyslipidemia, l
246 or above the 90th percentile or diagnosis of elevated blood pressure or PHTN were eligible for data t
247 Fit persons with any combination of smoking, elevated blood pressure, or elevated cholesterol level h
248 mia, low high-density lipoprotein [HDL], and elevated blood pressure) (P-trend for all tests <= 0.001
249 scular risk factors in midlife (specifically elevated blood pressure, physical inactivity, smoking, a
251 ut tuberculosis, elevated blood glucose, and elevated blood pressure poorly diagnosed and treated.
252 ozygote subjects showed reduced cortisol and elevated blood pressure, predicting risk of anxiety and
253 betes mellitus, obstructive sleep apnea, and elevated blood pressure predispose to AF, and each facto
254 fidence interval [CI], 1.03-1.16), number of elevated blood pressure readings beyond 3 (OR, 1.77; 95%
255 (OR, 1.21; 95% CI, 1.09-1.34) and number of elevated blood pressure readings beyond 3 (OR, 3.07; 95%
256 ticipants met the primary outcome: 37.2% had elevated blood pressure readings, 60.5% elevated body ma
257 olled cardiovascular risk factor, defined as elevated blood pressure readings, elevated body mass ind
258 ishing vascular function with age, including elevated blood pressure, reduced vascular compliance, de
260 lts from nonadherence to medications or from elevated blood pressure related to the white coat syndro
261 to 3.0) in the dexamethasone-placebo group, elevated blood pressure (relative risk, 2.9; 95 percent
263 tant in processing acupuncture modulation of elevated blood pressure responses through a PVN opioid m
265 izziness (RR, 5.81; 95% CI, 1.02-33.03), and elevated blood pressure (RR, 2.29; 95% CI, 1.15- 4.53) w
266 d diastolic blood pressure [dBP] <80 mm Hg), elevated blood pressure (sBP 120-129 mm Hg and dBP <80 m
267 esponses to oral sodium loads in addition to elevated blood pressure (see related article beginning o
268 no overt obesity, severe hydrocephalus, and elevated blood pressure (shared by some but not all BBS
269 Leading health organizations agree that elevated blood pressure should be managed in children; h
271 During the index event, most patients had elevated blood pressure, sinus tachycardia, minimal nons
273 use and increased risks of heart failure and elevated blood pressure, subsequent studies found a link
274 es showed preserved cardiac function despite elevated blood pressure, suggesting sex-based difference
275 is: fasting glucose > 100 mg/dL or diabetes; elevated blood pressure (systolic >/= 130 mm Hg, diastol
276 y mass index [BMI] of 30 kg/m(2) or higher), elevated blood pressure (systolic blood pressure of 130
277 rate that excitation of PVN(Agtr1a) promotes elevated blood pressure that is dependent on the sympath
278 Although mice deficient in GC-A display an elevated blood pressure, the resultant cardiac hypertrop
279 18 years or older with known hypertension or elevated blood pressure, those with dyslipidemia, or tho
281 onolactone treatment reversibly restored the elevated blood pressure to the BKbeta1(+/+) strain A lev
282 adults (aged 55-88, mean age 69.9 [8.2 SD]), elevated blood pressure variability over 5 min was assoc
285 Between 2006 and 2016, a lower likelihood of elevated blood pressure was observed (relative risk for
287 orderline or elevated risk factors, of which elevated blood pressure was the most important contribut
289 ildren and adolescents with hypertension and elevated blood pressure were identified using direct ass
292 erence and the white coat effect, defined as elevated blood pressure when measured in clinic but cont
293 clase-A (GC-A) results in mice displaying an elevated blood pressure, which is not altered by high or